Ubs Group Ag Dare Bioscience, Inc. Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 500 shares of DARE stock, worth $170. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500

Previous 8,600 94.19%

Holding current value

$170

Previous $2,000 100.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.31 - $0.57 $2,511 - $4,617	-8,100 Reduced 94.19%	500 $0
Q4 2023 Feb 09, 2024	BUY	$0.29 - $0.53 $2,349 - $4,293	8,100 Added 1620.0%	8,600 $2,000
Q1 2023 May 12, 2023	SELL	$0.87 - $1.36 $23,855 - $37,291	-27,420 Reduced 98.21%	500 $0
Q4 2022 Feb 08, 2023	SELL	$0.82 - $1.03 $23,429 - $29,429	-28,572 Reduced 50.58%	27,920 $23,000
Q3 2022 Nov 10, 2022	BUY	$1.04 - $1.27 $58,231 - $71,109	55,992 Added 11198.4%	56,492 $57,000

Q2 2022 Aug 10, 2022	SELL	$0.94 - $1.76 $4,479 - $8,386	-4,765 Reduced 90.5%	500 $1,000
Q1 2022 May 16, 2022	SELL	$1.42 - $2.09 $14,008 - $20,617	-9,865 Reduced 65.2%	5,265 $8,000
Q4 2021 Feb 14, 2022	BUY	$1.42 - $2.13 $20,774 - $31,161	14,630 Added 2926.0%	15,130 $30,000
Q3 2021 Nov 15, 2021	SELL	$1.42 - $2.0 $14,856 - $20,924	-10,462 Reduced 95.44%	500 $1,000
Q2 2021 Aug 13, 2021	BUY	$1.21 - $1.89 $12,659 - $19,773	10,462 Added 2092.4%	10,962 $21,000
Q2 2020 Jul 31, 2020	SELL	$0.84 - $1.11 $31,921 - $42,182	-38,002 Reduced 98.7%	500 $0
Q1 2020 May 01, 2020	BUY	$0.79 - $1.7 $30,416 - $65,453	38,502 New	38,502 $32,000
Q3 2019 Nov 14, 2019	SELL	$0.74 - $0.87 $93 - $109	-126 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.79 - $1.66 $5,646 - $11,864	-7,147 Reduced 98.27%	126 $0
Q1 2019 May 14, 2019	BUY	$0.73 - $2.1 $1,637 - $4,710	2,243 Added 44.59%	7,273 $10,000
Q4 2018 Feb 14, 2019	BUY	$0.63 - $1.12 $2,979 - $5,297	4,730 Added 1576.67%	5,030 $4,000
Q3 2018 Nov 14, 2018	SELL	$0.92 - $1.43 $5,123 - $7,963	-5,569 Reduced 94.89%	300 $0
Q2 2018 Aug 14, 2018	BUY	$0.76 - $1.48 $4,057 - $7,901	5,339 Added 1007.36%	5,869 $7,000
Q1 2018 May 15, 2018	SELL	$0.83 - $2.79 $3,082 - $10,362	-3,714 Reduced 87.51%	530 $0
Q4 2017 Feb 14, 2018	SELL	$2.16 - $3.35 $995 - $1,544	-461 Reduced 9.8%	4,244 $9,000
Q3 2017 Nov 14, 2017	BUY	$2.63 - $3.52 $12,374 - $16,561	4,705	4,705 $14,000

Others Institutions Holding DARE

# of Institutions

Shares Held

6.86M

Call Options Held

Put Options Held

View Full List

About Dare Bioscience, Inc.

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $28.8M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

More about DARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account